Company Filing History:
Years Active: 2025
Title: Innovations of Simon Aberg in Botulinum Toxin Purification
Introduction
Simon Aberg is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the purification of botulinum toxin. His innovative methods have the potential to enhance the safety and efficacy of botulinum toxin applications.
Latest Patents
Simon Aberg holds a patent for a method of purifying botulinum toxin. This technology relates to commercial-scale methods for purifying botulinum toxin compositions obtained from cell cultures. The purification methods are based on a series of filtration and chromatographic separation steps that produce a high-purity botulinum toxin composition. This composition comprises botulinum toxin protein molecules (approximately 150 kDa) in solution, which is free, essentially free, or substantially free of botulinum toxin complexes and animal products. Importantly, the method does not involve precipitation, lyophilization, or centrifugation steps, allowing for the production of highly pure, highly active, free botulinum toxin protein molecules in solution.
Career Highlights
Simon Aberg is associated with Galderma Holding SA, a company known for its focus on dermatological products. His work in this organization has allowed him to apply his innovative purification methods in practical settings.
Collaborations
Some of his notable coworkers include Ulf Stahl and Peter Frank, who have collaborated with him on various projects related to botulinum toxin purification.
Conclusion
Simon Aberg's contributions to the field of botulinum toxin purification represent a significant advancement in biotechnology. His innovative methods promise to improve the quality and safety of botulinum toxin applications in various industries.